Literature DB >> 6579550

Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.

B Teng, G R Thompson, A D Sniderman, T M Forte, R M Krauss, P O Kwiterovich.   

Abstract

Hyperapobetalipoproteinemia is defined as the combination of a normal low density lipoprotein (LDL) cholesterol in the face of an increased LDL apolipoprotein B (apoB) protein. To examine the physical basis for the apparent disproportion between LDL cholesterol and apoB characteristic of this syndrome, we used density gradient ultracentrifugation to isolate LDL fractions from 10 normal subjects, from 20 patients with hyperapobetalipoproteinemia (10 normotriglyceridemic and 10 hypertriglyceridemic), and from 7 patients with familial hypercholesterolemia. In familial hypercholesterolemia, more LDL was in fraction 1--"light" LDL--and this LDL was relatively enriched in cholesterol and poor in protein. By contrast, it was fraction 2--"heavy" LDL--that differed in hyperapobetalipoproteinemia, being denser, depleted of cholesterol (particularly cholesteryl ester), and relatively enriched in apoB. These findings were more pronounced in the hypertriglyceridemic patients than in the normotriglyceridemic patients with hyperapobetalipoproteinemia. Thus this study confirms that considerable heterogeneity exists between LDL subfractions within individuals but, in addition, indicates there are also marked--and apparently characteristic--differences in LDL composition amongst normal subjects and patients with hyperapobetalipoproteinemia or familial hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6579550      PMCID: PMC391230          DOI: 10.1073/pnas.80.21.6662

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Reversible abnormalities of low density lipoprotein composition in familial hypercholesterolaemia.

Authors:  A V Jadhav; G R Thompson
Journal:  Eur J Clin Invest       Date:  1979-02       Impact factor: 4.686

2.  Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins.

Authors:  J L Witztum; G Schonfeld; S W Weidman; W E Giese; M A Dillingham
Journal:  Metabolism       Date:  1979-03       Impact factor: 8.694

3.  Predictable changes in low density lipoprotein composition after acute myocardial infarction.

Authors:  A D Sniderman; B Teng
Journal:  Atherosclerosis       Date:  1977-07       Impact factor: 5.162

4.  Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia.

Authors:  P N Durrington; C H Bolton; M Hartog
Journal:  Clin Chim Acta       Date:  1978-01-02       Impact factor: 3.786

5.  Heterogeneity of serum low density lipoproteins in normal human subjects.

Authors:  M M Shen; R M Krauss; F T Lindgren; T M Forte
Journal:  J Lipid Res       Date:  1981-02       Impact factor: 5.922

6.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Authors:  A Sniderman; S Shapiro; D Marpole; B Skinner; B Teng; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

7.  Are apolipoproteins better discriminators than lipids for atherosclerosis?

Authors:  P Avogaro; G B Bon; G Cazzolato; G B Quinci
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

8.  Apoproteins and lipids as discriminators of severity of coronary heart disease.

Authors:  W F Riesen; R Mordasini; C Salzmann; A Theler; H P Gurtner
Journal:  Atherosclerosis       Date:  1980-09       Impact factor: 5.162

9.  Interrelationships among subgroups of serum lipoproteins in normal human subjects.

Authors:  R M Krauss; F T Lindgren; R M Ray
Journal:  Clin Chim Acta       Date:  1980-07-01       Impact factor: 3.786

10.  Abnormalities in lipoproteins of d < 1.006 g/ml in familial lecithin:cholesterol acyltransferase deficiency.

Authors:  J A Glomset; K Applegate; T Forte; W C King; C D Mitchell; K R Norum; E Gjone
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

View more
  21 in total

1.  Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.

Authors:  S G Young; S J Bertics; L K Curtiss; D C Casal; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

2.  Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.

Authors:  L Berglund; J L Witztum; N F Galeano; A S Khouw; H N Ginsberg; R Ramakrishnan
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

3.  Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

Authors:  K M Cianflone; M H Maslowska; A D Sniderman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 4.  Genetic influences on susceptibility to atherosclerosis in the young.

Authors:  P O Kwiterovich
Journal:  Bull N Y Acad Med       Date:  1989-12

5.  Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic.

Authors:  G Pairitz; J Davignon; H Mailloux; C F Sing
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

6.  Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

Authors:  B Teng; A D Sniderman; A K Soutar; G R Thompson
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II.

Authors:  P Kwiterovich; M Motevalli; M Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects.

Authors:  D Owens; S McBrinn; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

9.  Human apolipoprotein B: identification of cDNA clones and characterization of mRNA.

Authors:  M Mehrabian; V N Schumaker; G C Fareed; R West; D F Johnson; T Kirchgessner; H C Lin; X B Wang; Y H Ma; E Mendiaz
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

Review 10.  Physical activity and lipoprotein lipid disorders.

Authors:  A Berg; I Frey; M W Baumstark; M Halle; J Keul
Journal:  Sports Med       Date:  1994-01       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.